BioSpace News Archive

Genetown

Mersana Therapeutics Announces Launch of Oncology FACETS, a Resource for Healthcare Providers to Advance Knowledge in Gynecologic Malignancies

Mersana Therapeutics, Inc. today announced the launch of Oncology FACETS : an educational platform for healthcare providers that will address clinically impactful topics in gynecologic oncology.

September 30, 2022
·
4 min read
Genetown

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

scPharmaceuticals Inc. today announced two poster presentations, including a late breaker, at the Heart Failure Society of America (HFSA) 2022 Annual Meeting, which is being held September 30 – October 3, in Washington DC.

September 30, 2022
·
8 min read
BioCapital

Synthetic Biologics Announces Presentation at SIOP International Society of Pediatric Oncology on New Preclinical Data Supporting Evaluation of VCN-01 and Topotecan for the Treatment of Refractory Retinoblastoma

Synthetic Biologics, Inc. today announced the presentation of new data from collaborators at Fundació Sant Joan de Déu that further support evaluation of VCN-01, an oncolytic adenovirus expressing hyaluronidase, and topotecan for the treatment of refractory retinoblastoma.

September 30, 2022
·
6 min read
Biotech Beach

Eargo to Hold Investor Update Conference Call on October 4, 2022

Conference Call to be held on Tuesday, October 4, 2022 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) VOTE now to ensure the Company can conduct its proposed rights offering and repay or convert the convertible notes held by Patient Square Capital.

September 30, 2022
·
9 min read
Genetown

EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing

EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing.

September 30, 2022
·
5 min read
Drug Development

Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study

Edesa Biotech, Inc. announced final results from the Phase 2 portion of its ongoing Phase 2/Phase 3 clinical study.

September 30, 2022
·
10 min read
ALR Technologies Announces Update to Singapore Migration Merger and GluCurve Pet CGM Commercialization

ALR Technologies Inc., the diabetes management company, is pleased to announce an update with respect to its migration to Singapore.

September 30, 2022
·
11 min read
Biotech Bay

ValGenesis and QbD Pharmaceutical Services Partner to Deliver Best-in-Class Quality by Design and Process Validation and Verification Services for Life Sciences Companies

ValGenesis, Inc and QbD Pharmaceutical Services have partnered to deliver best-in-class quality by design and process validation and verification services for the life sciences industry across Europe and South America.

September 30, 2022
·
3 min read
Business

Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders

Navidea Biopharmaceuticals, Inc. today announced the appointment of Joshua (“Josh”) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company’s 2024 annual stockholders’ meeting.

September 30, 2022
·
7 min read
Biotech Beach

Forza Innovations Announces Completion of New Funding Round

Forza Innovations Inc. today announced the completion of a new tranche of funding, totaling $250,000.

September 30, 2022
·
3 min read